Zacks.com on MSN
Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates
Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.51 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.9 per share a year ago. These ...
"The FDA approval of Optune Pax marks the first new treatment in decades for people living with locally advanced pancreatic cancer," said Frank Leonard, CEO of Novocure. "Optune Pax is a fundamentally ...
Alysa Liu was divine in the women’s figure skating short program and other news from Day 11 of the Winter Olympics.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2025 Earnings Call Transcript February 17, 2026 Halozyme Therapeutics, Inc.
Appointment is a positive endorsement of NovaBridge’s unique hub-and-spoke model and focus on creating shareholder value by accelerating the ...
The second full week of the Milan and Cortina Winter Olympics is underway and there are so many highly anticipated competitions on Wednesday.
Ye, formerly Kanye West, took out a full-page ad in the Wall Street Journal to apologize, saying a long manic episode in 2025 ...
You are listening to the audio webcast of the presentation of the annual results 2025 of Royal Heijmans. In the upcoming minutes, you will hear at first our CEO, Mr. Ton Hillen, followed by our CFO, ...
Q4 2025 Earnings Call February 9, 2026 8:30 AM ESTCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit Batra ...
The global landscape for biological fermentation is entering a period of disciplined, high-volume consolidation. According to the latest strategic outlook by Future Market Insights (FMI), the global ...
The company building the largest data center in NJ say theirs is a eco-friendly facility, but skeptics worry about water and pollution problems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results